Get Your Personalized Supplement StackSupplement Stack Quiz

Bifidobacterium Longum Lb21

Q: Is BL21 effective for weight loss?

While BL21 did not significantly reduce body weight compared to placebo in a human trial, it did show benefits in improving lipid profiles, specifically reducing triglyceride levels, in overweight adults.

Q: Can BL21 improve reproductive health?

Animal studies suggest potential benefits for sperm quality and PCOS-related hormonal balance. However, human data are currently lacking, and further research is needed to confirm these effects in humans.

Q: Is BL21 safe for long-term use?

Short-term use of BL21 appears safe with no serious adverse events reported. Long-term safety data are limited but are generally consistent with the safety profiles of other well-studied probiotic strains.

Q: How soon can I expect to see benefits from BL21?

In human studies, metabolic effects such as triglyceride reduction were observed after 8 weeks of supplementation. In animal models, reproductive and gut barrier effects varied from weeks to months.

Also known as: Bifidobacterium longum BL21, probiotic BL21, BL21, Bifidobacterium longum subsp. longum BL21

Overview

Bifidobacterium longum subsp. longum BL21 is a specific probiotic bacterial strain naturally residing in the human gut microbiota. It is utilized as a dietary supplement primarily to modulate gut health and metabolic functions. Key applications include supporting metabolic health, such as managing triglyceride levels in overweight individuals, and showing promise in reproductive health, particularly in animal models for conditions like polycystic ovarian syndrome (PCOS) and sperm quality. This strain is characterized by its ability to alter gut microbiota composition, influence various metabolic pathways, and reduce inflammation. Research, including randomized controlled trials (RCTs) and mechanistic studies in both humans and animal models, suggests its potential benefits, though large-scale meta-analyses specifically on BL21 are still emerging. It is generally considered safe with no serious adverse events reported in human trials.

Benefits

Bifidobacterium longum BL21 offers several evidence-based benefits, particularly in metabolic and reproductive health. In metabolic health, an 8-week randomized controlled trial involving 66 overweight/obese adults demonstrated that BL21 (2×10^10 CFU/day) significantly reduced triglyceride levels (p=0.04) and altered gut microbiota diversity, although it did not significantly impact body weight. This suggests a moderate but statistically significant effect on lipid metabolism. For reproductive health, animal studies provide promising insights: in zebrafish models, BL21 significantly improved sperm count, viability, and reduced DNA fragmentation (p<0.001), indicating a protective effect on sperm quality. In PCOS mouse models, BL21 modulated gut microbiota, reduced inflammation, and improved sex hormone balance, suggesting potential benefits for managing PCOS symptoms. Furthermore, BL21 has been shown to improve gut tissue integrity and the mucus layer in T2DM mouse models, highlighting its role in gut barrier function. The strain also modulates gut microbiota composition by increasing beneficial genera like *Bifidobacterium* and *Bacteroides*, which correlates with improved inflammatory and hormonal profiles. While human data for reproductive benefits are preclinical, the metabolic effects in humans are supported by a well-designed RCT.

How it works

Bifidobacterium longum BL21 exerts its effects primarily by modulating the gut microbiota composition, leading to an increase in beneficial bacterial genera that positively influence host metabolism and immune responses. It impacts various metabolic pathways, including sphingolipid and biotin metabolism, and protein digestion/absorption. The strain demonstrates anti-inflammatory properties by reducing pro-inflammatory cytokines such as TNF-α and IL-6, while potentially increasing anti-inflammatory markers like IL-10. BL21 also plays a role in enhancing gut barrier integrity by improving mucin production and the structural integrity of gut tissue, thereby influencing the gut–liver axis. In reproductive contexts, it is believed to reduce oxidative stress and DNA fragmentation in sperm cells through its antioxidant and anti-inflammatory pathways. While BL21 acts locally within the gut, its metabolic byproducts and interactions with the host microbiota mediate systemic effects.

Side effects

Bifidobacterium longum BL21 appears to have a favorable safety profile, with no serious adverse events reported in human clinical trials. As with many probiotics, mild gastrointestinal symptoms such as bloating, gas, or abdominal discomfort may theoretically occur in some individuals, though these were not specifically documented for BL21 in the provided research. There are no reported significant drug interactions or contraindications specific to BL21. However, general caution is advised for immunocompromised individuals due to the theoretical risk of infection from live bacterial strains, although no such cases have been reported for BL21. Pregnant or breastfeeding individuals should consult a healthcare professional before use, as specific data for these populations are limited. Overall, BL21 is considered safe for short-term use, but long-term safety data are still being gathered, consistent with the broader understanding of probiotic safety.

Dosage

The effective dosage for Bifidobacterium longum BL21, as demonstrated in human randomized controlled trials, is 2×10^10 Colony Forming Units (CFU) per day, administered for a duration of 8 weeks. While there is no established maximum safe dose, typical probiotic dosages generally range from 10^9 to 10^11 CFU daily. Specific timing for administration has not been definitively reported, but probiotics are often recommended to be taken with meals to enhance their survival through the acidic environment of the stomach. BL21 is typically available in forms such as capsules or powder, often mixed with excipients like maltodextrin, as used in research studies. The efficacy of BL21 is dependent on its ability to survive gastric transit and colonize the gut, which it has demonstrated. Adherence to the recommended dosage is important, and individuals should consult healthcare professionals for personalized advice, especially for specific health conditions.

FAQs

Is BL21 effective for weight loss?

While BL21 did not significantly reduce body weight compared to placebo in a human trial, it did show benefits in improving lipid profiles, specifically reducing triglyceride levels, in overweight adults.

Can BL21 improve reproductive health?

Animal studies suggest potential benefits for sperm quality and PCOS-related hormonal balance. However, human data are currently lacking, and further research is needed to confirm these effects in humans.

Is BL21 safe for long-term use?

Short-term use of BL21 appears safe with no serious adverse events reported. Long-term safety data are limited but are generally consistent with the safety profiles of other well-studied probiotic strains.

How soon can I expect to see benefits from BL21?

In human studies, metabolic effects such as triglyceride reduction were observed after 8 weeks of supplementation. In animal models, reproductive and gut barrier effects varied from weeks to months.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC12273011/ – This randomized controlled trial investigated the effects of BL21 in 66 overweight/obese adults over 8 weeks. It found that BL21 significantly reduced triglyceride levels and altered gut microbiota diversity, although it did not lead to significant body weight reduction compared to placebo. The study highlights BL21's potential in metabolic health modulation.
https://www.nature.com/articles/s41598-025-97721-w – This animal study used a zebrafish model of cyclophosphamide-induced reproductive dysfunction. It demonstrated that BL21 significantly improved sperm count, viability, and reduced DNA fragmentation, suggesting a protective role for BL21 in male reproductive health. This provides preclinical evidence for its potential in fertility support.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10505128/ – This animal study, with context from a meta-analysis, explored the effects of BL21 in T2DM mice. It showed that BL21 improved gut tissue integrity and the mucus layer, reducing gut damage. This research supports BL21's role in enhancing gut barrier function, which is crucial in metabolic disorders.
https://journals.asm.org/doi/10.1128/msphere.00887-24 – This animal study investigated BL21 in a PCOS mouse model. It found that BL21 modulated gut microbiota, reduced inflammation, and improved sex hormone balance. This provides mechanistic and preclinical evidence for BL21's potential benefits in managing symptoms associated with polycystic ovarian syndrome.
https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/06/e998.pdf – This systematic review and meta-analysis focused on a related strain, B. longum 35624, in IBS patients. While not directly on BL21, it provides high-level evidence for the efficacy of specific B. longum strains in reducing IBS symptoms, lending indirect support to the plausibility of benefits from other B. longum strains like BL21 in gut-related conditions.